Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia

Toimittaja(t)

Centers for Disease Control and Prevention (CDC)
23-1393.pdf
514.99 KB
Lataukset32

Pysyvä osoite

https://urn.fi/URN:NBN:fi-fe2025082792848

Verkkojulkaisu

DOI

10.3201/eid3011.231393

Tiivistelmä

In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.

item.page.okmtext

Tietueen kaikki tiedot